Barba, Pere <br/><br/>
Increased survival due to lower toxicity for high-risk T-cell acute lymphoblastic leukemia patients in two consecutive pediatric-inspired PETHEMA trials.  [electronic resource] 

 -  European journal of haematology  Jan 2019 
 - 79-86 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article 
<br/><br/><label>ISSN: </label>1600-0609 
<br/><br/><label>Standard No.: </label>10.1111/ejh.13178  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Antineoplastic Combined Chemotherapy Protocols--adverse effects<br/>Combined Modality Therapy<br/>Consolidation Chemotherapy<br/>Female<br/>Genetic Testing<br/>Hematopoietic Stem Cell Transplantation<br/>Humans<br/>Immunophenotyping<br/>Induction Chemotherapy<br/>Male<br/>Middle Aged<br/>Precursor T-Cell Lymphoblastic Leukemia-Lymphoma--diagnosis<br/>Recurrence<br/>Risk Factors<br/>Transplantation, Homologous<br/>Treatment Outcome<br/>Young Adult